Zenas BioPharma, Inc./$ZBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zenas BioPharma, Inc.
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
Ticker
$ZBIO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
130
ISIN
US98937L1052
Website
ZBIO Metrics
BasicAdvanced
$479M
-
-$7.00
-
-
Price and volume
Market cap
$479M
52-week high
$12.41
52-week low
$6.11
Average daily volume
145K
Financial strength
Current ratio
6.468
Quick ratio
6.393
Long term debt to equity
0.111
Total debt to equity
0.431
Management effectiveness
Return on assets (TTM)
-56.70%
Return on equity (TTM)
-115.47%
Valuation
Price to revenue (TTM)
17.756
Price to book
1.68
Price to tangible book (TTM)
1.68
Price to free cash flow (TTM)
-1.933
Growth
Revenue change (TTM)
-70.00%
Earnings per share change (TTM)
-76.46%
ZBIO News
AllArticlesVideos

Lost Money on Zenas BioPharma, Inc. (ZBIO)? Contact Levi & Korsinsky to Join Class Action Before June 16, 2025
Accesswire·1 hour ago

ZBIO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zenas BioPharma, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Accesswire·2 hours ago

Contact Levi & Korsinsky by June 16, 2025 to Join Class Action Against Zenas BioPharma, Inc. (ZBIO)
Accesswire·13 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zenas BioPharma, Inc. stock?
Zenas BioPharma, Inc. (ZBIO) has a market cap of $479M as of May 23, 2025.
What is the P/E ratio for Zenas BioPharma, Inc. stock?
The price to earnings (P/E) ratio for Zenas BioPharma, Inc. (ZBIO) stock is 0 as of May 23, 2025.
Does Zenas BioPharma, Inc. stock pay dividends?
No, Zenas BioPharma, Inc. (ZBIO) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Zenas BioPharma, Inc. dividend payment date?
Zenas BioPharma, Inc. (ZBIO) stock does not pay dividends to its shareholders.
What is the beta indicator for Zenas BioPharma, Inc.?
Zenas BioPharma, Inc. (ZBIO) does not currently have a Beta indicator.